Steadtrust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Steadtrust's NVS Position: Q2 2026 in Review
Steadtrust increased its Novartis (NVS) stake by 0.03% in Q2 2026, buying an estimated $300 and bringing the position to 5,769 shares worth $904K. The position accounts for 0.46% of the portfolio, ranked #55.
Steadtrust first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Steadtrust held 5,769 shares of Novartis worth $904K as of Q2 2026.
- Steadtrust bought 2 Novartis shares in Q2 2026, an estimated $300.
- Novartis made up 0.46% of Steadtrust's portfolio in Q2 2026, its #55 holding.
- Steadtrust first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
- 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.